Advertisement
UK markets close in 2 hours 55 minutes
  • FTSE 100

    8,115.26
    +36.40 (+0.45%)
     
  • FTSE 250

    19,792.46
    +190.48 (+0.97%)
     
  • AIM

    754.73
    +1.61 (+0.21%)
     
  • GBP/EUR

    1.1671
    +0.0015 (+0.13%)
     
  • GBP/USD

    1.2517
    +0.0006 (+0.05%)
     
  • Bitcoin GBP

    51,402.47
    +387.38 (+0.76%)
     
  • CMC Crypto 200

    1,387.84
    -8.69 (-0.62%)
     
  • S&P 500

    5,048.42
    -23.21 (-0.46%)
     
  • DOW

    38,085.80
    -375.12 (-0.98%)
     
  • CRUDE OIL

    84.19
    +0.62 (+0.74%)
     
  • GOLD FUTURES

    2,355.80
    +13.30 (+0.57%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • HANG SENG

    17,651.15
    +366.61 (+2.12%)
     
  • DAX

    18,052.61
    +135.33 (+0.76%)
     
  • CAC 40

    8,050.92
    +34.27 (+0.43%)
     

Biotech Stocks Crispr, Editas, Intellia Fall On Gene-Editing Study

Biotech Stocks Crispr, Editas, Intellia Fall On Gene-Editing Study

Shares in biotech stocks Crispr Therapeutics, Editas Medicine and Intellia Therapeutics fell after a scientific publication reported that gene-editing techniques might cause cancer.